vascular fibrin formation were studied; ( I ) patients with preeclampsia; (2) those having treatment with ancrod (Arvin).
In preeclampsia, soluble fibrin formation was greatly. increased in comparison with normal pregnant women. The isolated fibrin contained intact a, p and 7 chains; on polyacrylamide gel electrophoresis, no crosslinking of y chains could be found. A positive correlation was found, in fresh plasma samples, between the concentration of soluble fibrin as measured by affinity chromatography and the concentration of. soluble fibrin-fibrinogen complexes as measured by agarose gel filtration. It appears that these soluble fibrin complexes consist of a mixture of fibrinogen and fibrin in a 1 :I ratio.
During ancrod therapy, soluble fibrin was found in greatly increased amounts, and could be separated into two types by affinity chromatography. The greater part had a reduced a chain content, and could be eluted from the affinity column at 37°C. The smaller part had intact a chain and was not eluted at 37"C, suggesting that the extent and type of complex formation is dependent upon temperature.
The fact that complexes are partially degraded during ancrod infusion suggests that they are formed by degradation of fibrin which is unstable due to the absence of crosslinking by factor XIII. In contrast, the fibrin complexes in preeclampsia may represent the early formation of fibrin which, if polymerization continues, may lead to intravascular fibrin deposition.
THE EFFECTS O F THERAPY AND SPLENECTOMY ON IMMUNITY IN MALIGNANT LYMPHOMA B. W. HANCOCK, LESLEY BRUCE, A. MILFORD WARD and JOHN RICHMOND Departmenfs of Medicine and finniirriology. Universitv of She ffield
The immune status of eighty-five patients with malignant lymphoma (fifty-six with Hodgkin's disease, twenty-nine with non-Hodgkin's lymphoma) has been assessed at presentation and after radical radiotherapy or during intensive chemotherapy. Twenty-six of the patients with Hodgkin's disease underwent diagnostic laparotomy with splenectomy; the effects of splenectomy on immunity were aslo studied. Only patients responding clinically to therapy have been included in the study. Cellular immunity was studied by intradermal skin tests with multiple recall antigens and by leucocyte migration inhibition with Candida and PPD. Serum immunoglobulins were measured as an index of humoral immunity. In addition to monitoring white cell counts, neutrophil phagocytic and killing functions were assessed.
In all groups the lymphocyte and neutrophil counts fell with therapy though to a lesser extent in the splenectomized patients. Neutrophil function was essentially unchanged by splenectomy or therapy. Cellular immunity (as assessed by combining skin and leucocyte migration results) deteriorated in all groups. Depression of skin test reactivity was seen mainly in patients having chemotherapy. We have recently reported out early observations on the effects of splenectomy on immunity in Hodgkin's disease (Hancock, Bruce, Ward & Richmond, 1976, British Medical Journal, i, 313). Further studies confirm that cellular immunity after treatment was not influenced by splenectomy, whereas serum IgA and particularly IgM levels fell significantly with treatment in splenectomized patients; such changes in humoral immunity were not seen in non-splenectomized patients. From this study it appears that irrespective of splenectomy some impairment of cellular immunity may occur with concentional treatment of malignant lymphoma, particularly combination chemotherapy. In splenectomized patients serum IgA and IgM may fall with treatment; this may be a predisposing factor in the development of systemic bacterial infection. being one of the.most potent. However, it does not prolong platelet survival and there is no convincing evidence from clinical trials that it is effective in arterial thromboembolic disease in man. Sulphinpyrazone (SP) is a weak inhibitor of platelet aggregation and release, but does prolong platelet survival in man.
PLATELET ADHESION
ASA and SP were examined for their effect on the adhesion reaction between isolated platelets and subendothelium exposed to balloon catheterization of rabbit aorta. Rabbit aorta was dissected to provide a leak-free tube, suspended in Tyrode's solution at 37'C and perfused with washed rabbit platelets which had been labelled with sodium 5 I-chromate, and were suspended in Tyrode's solution containing albumin and apyrase. After 10 min perfusion, radioactivity in the aortic sample was measured and platelet adhesion then calculated per mm2 of exposed surface. Two samples were perfused simultaneously with control of drug-treated suspension. Adhesion was reduced to 40% of control by SP 250pmol P (P<O.OOI) and to 55% of control by SP 25 pmoll-I (P<O.OS). ASA at 1.2 mniol I-', which inhibits collagen-induced platelet 3ggregatiot-1, did not significantly reduce adhesion.
Results from a similar system had previously shown that ASA inhibited platelet adhesion to collagen-coated glass, and to scraped rabbit aorta averted on a rotating probe. When balloondamaged aorta was tested in this system, ASA appeared
